Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-003041-41Phase 2Completed
Phase 2, randomised trial of coagulation factor X human in intraoperative bleeding and Not applicable (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Recruitment rate and intervention delivery and Trial process feasibility. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-003041-41.